XAN stock: buy or sell?

XAN stock price: $1.67 57.55% At close on April 6th, 2020

Updated on:
April 6th, 2020


After sliding a bloodcurdling -51.89% on Friday, Exantas Capital closed today at $1.67 and boosted an exceptional 57.55%.

Should I buy XAN stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. That's why is so important to define your own trading plan that matches with your character as inversor. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

Currently, Exantas Capital stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Exantas Capital stock a buy?

Financial institutions and banks publish stock ratings everyday. Unfortunately, we couldn't find any rating for XAN stock for the last month.

XAN stock analysis

Daily outlook

After sliding a bloodcurdling -51.89% on Friday, Exantas Capital closed today at $1.67 and boosted an exceptional 57.55%.

After sliding a bloodcurdling -51.89% on Friday, Exantas Capital closed today at $1.67 and boosted an exceptional 57.55%. Since last Mar 5th when XAN stock price broke down the SMA200d line, it slid $-8.45 per share (-83.50%). XAN marked a lower low and a lower high in the short term, defining a downward trend. Climbing above $3.30 would break this short term down trend and open possibilities for reversing this situation.

XAN stock chart (daily)

Weekly outlook

Last week XAN collapsed a dreadful -129.25% in just one week. After sliding a dreadful -129.25% in a week last week, Exantas Capital closed this week at $1.67 and climbed an outstanding 57.55%. After 4 weeks sliding, this week raised a 25.10%.

Since price and 40-weeks moving average lines crossed down early March, XAN fell $-8.62 per share (-83.77%). Trading stocks that are below the 40-weeks (that is, 200-days) moving average mark is not recommended by many experts, as it indicates that the stock has not enough institutional support.

XAN stock chart (weekly)

XAN stock price history

XAN IPO was on February 7th, 2006 at $25.33 per share1. Since then, XAN stock declined a -93.40%, with a yearly average of -6.70%.

1: Adjusted price after possible price splits or reverse-splits.

XAN stock historical price chart

XAN stock reached 52-week highs on February 25th at $11.24, and all-time highs 2007-01-30 with a price of 33.78.

XAN stock price target

How much a stock will be priced tomorrow or next week is quite unpredictable However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last 30 days we have not found any price target for Exantas Capital stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

, Exantas Capital presented its financial report, posting a slightly good growth for the Earnings per Share (EPS). Experts expected $0.23 per share, but Exantas Capital posted $0.24.
XAN earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

In 2018, Exantas Capital annual sales plummed a bloodcurdling -18.98% to $47.87 million USD from $59.08 marked in 2017. When comparing 2018 vs 2017, on the other hand, profit margin (that is, the net income divided by revenues) remained steady a 0.54% to 57.30%.

XAN annual Sales and Income evolution
2013$166 M-$46 M28.0%-
2014$125 M-24.77%$61 M49.1%31.76%
2015$138 M10.46%$11 M7.7%-82.75%
2016$57 M-58.81%$-30.37 M-53.5%-387.68%
2017$59 M4.19%$34 M56.8%-210.45%
2018$48 M-18.98%$27 M57.3%-18.22%

Quarterly financial results

Exantas Capital posted $13.82 million in revenues for 2018-Q4, a 4.44% improvement compared to previous quarter. Reported quarter earnings marked $9.95 M with a profit margin of 72.04%. Profit margin rose a 6.86% compared to previous quarter when profit margin was 65.19%. When comparing turnover to same quarter last year, Exantas Capital sales marked a dreadful loss and collapsed a -142.08%.
XAN quarterly Sales and Income evolution
2017-Q2$34 M-$13 M37.2%-
2017-Q3$-20 M-160.01%$19 M-91.4%47.38%
2017-Q4$-33 M60.78%$-2 M7.0%-112.40%
2018-Q1$6 M-118.78%$0 M1.8%-104.75%
2018-Q2$15 M137.63%$9 M59.6%7,844.55%
2018-Q3$13 M-9.71%$9 M65.2%-1.32%
2018-Q4$14 M4.44%$10 M72.0%15.42%

Exantas Capital ownership

When you are planning to invest in shares of a company, it's worth to review its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Exantas Capital, 3.10% of all outstanding shares are owned by its staff.

In case of Exantas Capital stock, 76.90% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for XAN stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Exantas Capital:

Market cap$53.5 M
Total shares32.1 M
Float shares28.4 M
  - Institutional holdings (%)76.9%
  - Insider holdings (%)3.1%
Shares in short selling0.0%

XAN summary

Monday, April 6th, 2020
Day range$1.20 - $2.40
Previous close$1.06
Session gain57.55%
Average true range$0.97
50d mov avg$7.98
100d mov avg$9.24
200d mov avg$9.54
Daily patternlb06a
Weekly pattern

Exantas Capital performance

To better understand Exantas Capital performance you must compare its gains with other related stocks in same sector or industry. We selected as the bechmarking frame for Exantas Capital stock.
XANExantas Capital-84.17%-83.18%-81.47%

Exantas Capital competitors

Unfortunately, we could not find any public company that could be defined as Exantas Capital competitor. This doesn't mean Exantas Capital does not have any competitor in the market, it's just we could not detected it.